ARCHIVES

Risk-Benefit Analysis Advised Prior To Hormone Therapy

This article is from The Cancer Letter archive.

Vol. 33 No. 8 | August 27, 2010

Download PDF Visit The Full Archive

Related Articles

Underpowered Study Of Evacet Dashes Approval Hopes

September 24, 1999

Four New Centers To Compete In ’84, DeVita Tells Pane

December 16, 1983

DCPC Developing Hispanic Cancer Control Intervention Program Concept

August 12, 1988

Pesticides Not Linked To High Rates Of Breast Cancer.

May 18, 2001

NCI Expects Centers To Increase Cancer Control Efforts Despite Various Obstacles They Face

January 16, 1987

Reimbursement Of Some Anticancer Drugs Expected To Drop Sharply Under HHS Policy.

June 30, 2000